NMD continued Flashcards

(35 cards)

1
Q

GBS presentation

A

Wide range of clinical findings
* Different degrees of involvement of motor, sensory and autonomic
fibres
* Different locations – spinal roots, cranial nerves, peripheral nerves
* Classic sensorimotor GBS (AIDP) is the most common - ~90% of cases
* ~10 days after antecedent event the earliest symptom is distal
paresthesia and low back pain (nerve root inflammation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GBS presentation / development

A
  • Earliest symptoms distal paresthesia & low back pain (nerve root
    inflammation)
  • ~10 days after antecedent event
  • Progressive, symmetric weakness - both proximal and distal muscles
  • Proximal due to nerve roots
  • Distal due to peripheral nerves
  • Commonly an ‘ascending pattern’ of weakness
  • legs earlier and weaker than arms
  • Hyporeflexia or areflexia in 90%
  • Cranial nerve involvement (facial > oropharyngeal > extraocular muscles)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GBS - other complications

A

Other complications:
* Respiratory muscle weakness, particularly diaphragm
* 10-30% need ventilator support
* Autonomic dysfunction in 2/3 of patients
* Cardiac arrhythmias
* Labile blood pressure
* Orthostatic hypotension
* Abnormal sweating
* GI dysmotility (can lead to ileus and bowel rupture)
* GU dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GBS investigations

A

CSF: Cytoalbuminological Dissociation
* High protein, normal cells

Nerve Conduction Studies
* Demyelination (or axonal) damage
* Can be delayed up to 14 days from symptom onset

MRI – enhancement of spinal nerve roots
* Antibody testing
* Campylobacter infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GBS tx

A

immunotherapy
* IVIG or Plasma exchange
* Remove autoantibodies
* Stop inflammatory response
* But do not reverse degree of nerve damage
* When started w/in 2 wks (IVIG) and 4 wks (PLEX) of onset of
weakness:
* reduce the time it takes for recovery

*repeating IVIg or plasma exchange if no response after initial tx will not benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GBS - supportive care

A

may need ICU if - dysautonomia, bulbar dysfunction, severe or worsening weakness, evolving resp distress

supportive care:
-DVT prophylaxis
- pain management
- bowel / bladder management
- decubitus ulcers
- fatigue
- psychiatric support
- future immunization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GBS prognosis

A
  • Functional recovery takes weeks to months
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hereditary Neuropathies

A

¡ Often Slow evolution, starting
in childhood or early adulthood
¡ Motor, sensory & autonomic
varieties identified
¡ Most are rare
¡ Most common type is “Charcot
Marie Tooth” neuropathy (high arches)
¡ Some with known genetic loci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

motor neuron diseases

A
  • A group of conditions
    characterized by injury to
    lower motor neurons
    (LMNs), upper motor
    neurons (UMNs) or both
  • Affect the cell body of the
    motor neuron, thus
    considered
    ‘neuronopathies’ rather
    than neuropathies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Amyotrophic Lateral Sclerosis

A
  • Incidence 2 per 100,000 people per year
  • Prevalence 5 per 100,000 people
  • 1.5 Men : 1 women
  • Most commonly presents between 60 and 75 years
  • Risk factors:
  • Age
  • Family history
  • Cigarette smoking
  • Other possible risk factors:
  • High levels of physical activity
  • Heavy metals
  • Toxins (pesticides)
  • Military service
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALS clinical features

A
  • Most common: asymmetric lower limb weakness, asymmetric upper limb
    weakness or bulbar manifestations
  • Each accounts for 25-30% of patients at presentation
    Limb weakness typically begins in distal muscles
  • Upper limb onset
  • Clumsiness
  • Difficulty with closing buttons or opening jars
  • Lower limb onset
  • Foot drop is most common
    Lack of pain or sensory symptoms
    Progression into more proximal muscles is expected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ALS - UMN vs LMN

A

LMN involvement
* Usually results in muscle cramps – painful and disruptive to sleep
* Fasciculations
UMN involvement
* Limb spasticity
* Slowness or stiffness of movement
* Difficulty with balance, falls
* Hyperreflexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ALS - bulbar manifestations

A

Bulbar Manifestations
* Mixed spastic-flaccid dysarthria
* Tongue atrophy and fasciculations (not really caused by other things)
* Dysphagia
* Pseudobulbar affect
* Uncontrollable and at times intrusive bouts of laughing or crying (frontal lobe pathology)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ALS - resp manifestations

A

Respiratory manifestations
* Weakness of diaphragm and other respirator muscles
* Dyspnea with exertion and at rest
* Sleep disordered breathing
* Orthopnea
* Weak cough, can’t clear secretions
* Shortness of breath with speaking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ALS - cognitive manifestations

A

Cognitive manifestations
* 50% of patients will have cognitive or behavioural dysfunction
* 15% will develop frontotemporal dementia
* Prognosis
* Between 17 and 90 months
* But variable
- accurate prediction is challenging despite staging and prognostic tools

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ALS management

A

Multidisciplinary Care
* Symptomatic and supportive care
* Respiratory
* Bulbar function
* Nutritional status
Disease modifying therapy
* Riluzole – longest standing treatment
* Inhibitor of glutaminergic excitotoxicity
* Increases survival vs. placebo by around 6-18 months

17
Q

ALS ddx

A
  • Cervical Myelopathy
  • Kennedy Disease
18
Q

cervical myelopathy

A
  • Can cause hyperreflexia and spasticity below the lesion
  • But AT the lesion – causes a lower motor neuron pathology
  • Can be due to cord compression
  • Or MRI negative
  • B12, Vitamin E, Copper deficiency
  • HIV, HTLV, syphilis, lyme
  • Autoimune
19
Q

kennedy disease

A
  • =spinobulbar muscular atrophy
  • X-linked CAG trinucleotide repeat expansion in androgen receptor
    gene
  • Boys and men from second to 6th decade of life
  • Motor neuronopathy
  • Sensory neuronopathy
  • Endocrine dysfunction – androgen insensitivity
  • Gynecomastia
  • Testicular atrophy, reduced fertility
  • Progression more gradual than ALS
20
Q

neuromuscular junction (NMJ) diseases

A
  • Proximal more than distal muscle weakness
  • Fatigable muscle weakness
  • muscle weakness worsens with use and improves with rest
  • e.g. worse at end of day, resolves in am, worse at end of meal, etc.
  • No sensory dysfunction
  • Myasthenia gravis is the most common disease involving the muscle-nerve
    junction
21
Q

Myasthenia Gravis

A
  • The most common disorder of the NMJ
  • Autoantiboties against various components of the post-synaptic
    muscle membrane
  • Characteristic fatigable weakness of ocular, bulbar, respirator, axial
    and limb muscles
  • Worsening dysfunction with exercise, use or toward the end of the
    day
22
Q

Myasthenia Gravis - Epidemiology

A
  • Rare disease, but incidence and prevalence have increased over time:
  • Due to increased recognition, better testing and better treatments
  • Incidence 5-30 / 1 million person-years
  • Prevalence 10-20 / 100,000 people
23
Q

Myasthenia Gravis – Clinical Features

A

2/3 of patients have weakness in ocular muscles as first symptom
* Diplopia or blurry vision during periods of extended visual effort
* Driving, reading, working on a computer, watching TV
* Eyelid droop or closure with eye use or when tired

Bulbar muscle weakness:
* Jaw muscle fatigue when chewing
* Coughing or aspirating when eating
* Fatigable slurred speech
* Lack of facial expression

Limb muscle weakness
* Trouble lifting arms over head to wash hair or face
* Trouble climbing stairs
* Trouble getting out of a low chair

24
Q

Myasthenia Gravis – Investigations

A
  • Antibody Testing
  • Acetylcholine Receptor Antibody – 75-90%
  • MUSK antibody – present in 1/3 of AChR
    negative patients
  • Electrodiagnostic testing
  • Repetitive nerve stimulation – decremental
    response due to fatigue
  • Association with Thymoma
  • All patients need CT chest once MG diagnosis
    is confirmed
25
Myasthenia Gravis – Treatment
Nonimmunosuppressive Agents * Pyridostigmine * Acetylcholinesterase inhibitor – increases ACh at the NMJ * Main side effects are diarrhea, drooling Immunotherapy * Prednisone * Steroid sparing (a few selected examples) * Azathioprine * Myocphenolate Mofetil * Cyclosporine * Rituximab * Myasthenic crisis: IVIG or Plasma Exchange
26
Myasthenia Gravis flare
* Infection – eg pneumonia * Iatrogenic * (you don’t need to know specific drugs, but be aware that some drugs can worsen MG) ex. BB, botulinum, aminoglycosides, fluroquinolones, macrolides, Mg IV,
27
Lambert Eaton Myasthenic Syndrome
* Antibodies against Voltage Gated Calcium Channels (VKCC) * Usually paraneoplastic associated with small cell lung cancer * Weakness IMPROVES with exercise! * more action potentials can open more channels
28
botulism
* Toxin produced by Clostridium botulinum cleaves SNARE proteins, inhibits release of acetylcholine into the NMJ
29
myopathies
muscle disease weakness - most often proximal and bilaterally symmetric § occasional conditions cause distal and/or asymmetric weakness ¡ Normal sensation ¡ Usually normal reflexes (reduced if chronic and severe) ¡ May see muscle atrophy (esp. chronic conditions) ¡ Normal or reduced muscle tone ¡ Pain (rarely and usually with destructive processes) ¡ Stiffness, cramping, contracture, myotonia (in specific conditions)
30
Muscle disease: useful clinical point
Muscle diseases usually present with proximal weakness and normal sensation. Nerve diseases are more likely to present with distal weakness and sensory loss.
31
Common Causes of Muscle Disease
¡ Acquired: § Inflammatory Myopathies – Dermatomyositis, Polymyositis § Toxic Myopathies – eg. Statin use § Endocrine Myopathies – eg hypo or hyperthyroidism ¡ Inherited: § Muscular dystrophies § Metabolic Myopathies (rare) § Channelopathies (rare)
32
Muscular dystrophies
* Inherited disorders causing progressive weakness & muscle atrophy * Genetic defect may produce abnormalities in other body systems along with muscle * Recognized according to clinical patterns, pattern of inheritance, and genetic testing. most common: - Duchenne’s and Becker’s muscular dystrophy - Myotonic muscular dystrophy
33
Duchenne muscular dystrophy
* Annual Incidence 2.1 per 10,000 * Prevalence 1.3-1.8 per 10,000 * Weak shoulder & pelvic girdle muscles * Pseudohypertrophy of calf muscles (due to muscle destruction and CT and fat deposition?) * Wheelchair bound by 10 years, death by 35 years. * X-linked recessive * Kyphoscoliosis & chest wall muscle weakness leads to resp. failure * Genetic defect: Dystrophin gene mutations * Often associated mild cognitive impairment, cardiomyopathy & conduction abnormalities * onset first decade
34
DMD - gower's sign
proximal muscle weakness requires use of arms to stand up from the ground - can't stand up wtih shoulder and hip extensors
35
myotonic muscular dystrophy
* Autosomal dominant * Defect : CTG repeat expansion in the DMPK (Dystrophic Myotonia Protein Kinase) gene * Variable clinical manifestations – severity correlates with number of CTG repeats * Muscle symptoms/signs: * Distal arm > leg weakness * Facial and neck weakness * Ptosis * Myotonia * Systemic (non-muscle) symptoms/signs: * Cognitive impairment, Cataracts, Insulin resistance/ diabetes, Cardiac conduction defects, GI dysfunction (e.g. constipation), Impaired sleep * Anticipation occurs - Myotonia in myotonic dystrophy: difficulty in releasing hand grip quickly